Ideally, preclinical cardiotoxicity screening efforts should efficiently detect unsafe compounds sufficiently early on in the drug discovery process to influence candidate drug selection, thus ...
Young, trained athletes may have abnormal 12-lead electrocardiograms (ECGs) without evidence of structural cardiac disease. Whether such ECG patterns represent the initial expression of underlying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback